Drugs / HXTC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02208167 | Apr 2015 → Jan 2017 | HIV infectious disease | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HXTC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02208167 ↗ |
| Modality | Cell therapy | “ex vivo expanded HIV-1 multi-antigen specific T-cell (HXTC) therapy” NCT02208167 ↗ |